IP Library Granted Patent US 10,973,770
Granted Patent B2
US 10,973,770 · App. 14/720,428 · Granted Apr 13, 2021

Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

Inventors: Ulf Fritz (Hirschhorn, DE); Olaf Fritz (Hirschhorn, DE); Thomas A. Gordy (Newnan, GA); Ronald Wojcik (Canton, GA); Jacques Blummel (Mannheim, DE); Alexander Kuller (Heidelberg, DE)
Assignee: Varian Medical Systems, Inc.
A61K9/5026A61K47/32A61K47/34A61K49/04A61K49/0404A61K49/1824A61K49/225A61M5/007A61M2205/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,973,770
App. No.
14/720,428
Granted
Apr 13, 2021
Kind
B2
Abstract

Polymeric particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene and/or a derivative thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Particles of the present invention may further be provided as color-coded microspheres or nanospheres to allow ready identification of the sized particles in use. Such color-coded microspheres or nanospheres may further be provided in like color-coded delivery or containment devices to enhance user identification and provide visual confirmation of the use of a specifically desired size of microspheres or nanospheres.

Claims (5)

1. A method of embolization in a mammal, comprising inserting polymeric particles into a blood vessel, each polymeric particle comprising;

a hydrogel core;

a barium sulfate coating covering the hydrogel core; and

an exterior coating covering the barium sulfate coating, the exterior coating comprising a polyphosphazene selected from poly[bis(2,2,2-trifluoroethoxy)]phosphazene or a derivative of poly[bis(2,2,2-trifluoroethoxy)]phosphazene,

wherein the polymeric particles are of sufficient size to occlude the blood vessel.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: VARIAN MEDICAL SYSTEMS, INC.
Reel/Frame 051511/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2016
From: CELONOVA BIOSCIENCES, INC.
To: BOSTON SCIENTIFIC LIMITED
Reel/Frame 038054/0341 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2015
From: FRITZ, ULF; FRITZ, OLAF; GORDY, THOMAS A.; WOJCIK, RONALD; BLÜMMEL, JACQUES; KÜLLER, ALEXANDER
To: CELONOVA BIOSCIENCES, INC.
Reel/Frame 036001/0027 →